TuesdaySep 27, 2022 10:47 am

ChineseNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC), New Investor Group Sign $3.67M Equity Investment Agreements

AnPac Bio-Medical Science (NASDAQ: ANPC), a biotechnology company with operations in the United States and China focused on early cancer screening and detection, has entered into legally binding investment agreements with nine institutional and individual investors; the agreements outline an investment in the company of approximately $3.67 million. According to the announcement, the various shares purchase agreements outline plans for a private offering of $3.67 million earmarked to purchase 36.7 million of the company’s Class A shares; the company anticipates that the investment will be complete this month. “This equity investment is important to the company’s operations as well as research and…

Continue Reading

ThursdayAug 11, 2022 9:58 am

ChineseNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Closes on $4M Funding Agreement

FingerMotion (NASDAQ: FNGR), a mobile data, services, and big data analytics company, announced that it has received $4 million in gross proceeds through a funding agreement with Lind Global Fund II, LP, which is an investment fund managed by New York-based institutional fund manager The Lind Partners. According to the announcement, the funds will provide transformational growth capital to scale Fingermotion’s business segments. The company noted that the funds are in the form of a securities purchase agreement that Lind Global purchased from FingerMotion, and the company has issued and sold to Lind Global a $4.8 million senior convertible note…

Continue Reading

TuesdayJul 19, 2022 12:11 pm

ChineseNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Releases Financial Report for Q1 2023

FingerMotion (NASDAQ: FNGR), a mobile services and data company, is reporting its financial results for first quarter 2023, which is the period ending May 31, 2022. A highlight of the report showed a record quarterly revenue of $4.86 million; the report noted that that number included FNGR’s SMS & MMS and telecommunications products & services businesses. The report also noted a 13% quarterly decline in the company’s telecommunications products & services business revenue, along with a quarterly cost of revenue of $4.48 million and a reported quarterly loss of $1.44 million. FNGR also noted that its big data business showed…

Continue Reading

FridayJul 15, 2022 12:57 pm

ChineseNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Unveils Mobile Device Protection Product in China

FingerMotion (NASDAQ: FNGR), a mobile data and services company, has launched a line of new mobile device protection products in China; the products are provided by FingerMotion’s subsidiary, Shanghai TengLian Jiujiu Information and Communication Technology Co. Ltd. (TengLian). The company noted that the distribution of these protection products has already begun, with the first phase of rollout happening in Hunan Province, which has a mobile subscriber base of 90 million; the company is planning phased rollouts in the months that will ultimately reach 1.2 billion subscribers. The products are available as embedded, value-added features on devices offered through Chinese carriers.…

Continue Reading

ThursdayJun 30, 2022 2:46 pm

ChineseNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Optimizing Product Offerings to Push Gross Margins Higher

FingerMotion (NASDAQ: FNGR) recently reported its financial results for the year ended February 28, 2022. “Annual revenue rose from $6.24 million in 2021 to $22.93 million in 2022, representing a 37% growth… For FY 2022, FingerMotion posted grows profits of $2.81 million, representing a 71% increase from the previous year. This was mainly achieved through the growth of the SMS & MMS business, which posted a 5% year-over-year (‘YoY’) growth, as well as Telecommunications Products and Services, which posted a 170% revenue growth from 2021. However, the sector that posted the highest growth was Big Data. Revenue for this sector…

Continue Reading

TuesdayJan 25, 2022 11:24 am

ChineseNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Ranked No. 1 Globally in Multi-Cancer Screening and Detection Test Volume

AnPac Bio (NASDAQ: ANPC), a biotechnology company with operations in the United States and China, today announced that Frost & Sullivan Company, a leading and well-known U.S. market analysis and research firm, has ranked AnPac Bio globally as number one in worldwide multiple cancer screening and detection volume in a recent research report. Based on data accumulated through the end of 2020, the report included next generation cancer screening and detection technologies, including circulating tumor cells (“CTCs”), circulating-DNA (“CT-DNA”), exosome, cancer differentiation analysis (“CDA”), mRNA, and other emerging technologies. Specifically, for next generation cancer screening and detection, the report ranked…

Continue Reading

TuesdayJan 18, 2022 3:27 pm

ChineseNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Releases Q3 2022 Financial Results

FingerMotion (NASDAQ: FNGR), a mobile data and services company, is reporting financial results for the third quarter, the period ended Nov. 30, 2021. Highlights of the report include quarterly revenue of $5.9 million, an increase of $1.02 million or 21% over Q3 2020; year-over-year quarterly growth in its telecommunications products & services business revenue of $2.8 million, a 580% increase over Q3 2020; quarterly loss in SMS & MMS business revenue of $1.78 million, or 40% compared to the same period in 2020; and no revenues in its big data division. In addition, the company showed gross profits of $967,075,…

Continue Reading

TuesdayJan 04, 2022 1:07 pm

ChineseNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Announces Engagement of Skyline Corporate Communications Group LLC for IR Services

FingerMotion (NASDAQ: FNGR), a mobile data and services company with evolving technology and a core competency in mobile payment and recharge platform solutions in China, today announced that it has recently retained the services of Skyline Corporate Communications Group LLC. Under the collaboration, Skyline will manage FingerMotion’s investor relations and corporate communications activities within the financial community. “Our Nasdaq listing along with our robust operating activities, growth objectives and expected corporate milestones prompted FingerMotion to select Skyline as our investor relations representative,” said Martin Shen, CEO of FingerMotion. “We believe that Skyline’s strong reputation, communications strategies, methodologies and standards are…

Continue Reading

MondayDec 27, 2021 11:32 am

ChineseNewsBreaks – FingerMotion Inc. (FNGR) to Begin Trading on NASDAQ Capital Market

FingerMotion (OTCQX: FNGR), a mobile data and services company, has announced that starting tomorrow, Dec. 28, 2021, its shares of common stock will be listed and available for trade on the Nasdaq Capital Market. The stock will be traded under the symbol FNGR. "FingerMotion is very proud and excited to be joining the Nasdaq stock market as one of their newly listed technology companies,” said FingerMotion CEO Martin Shen in the press release. “Listing on Nasdaq provides us greater exposure within the investment community as we execute on our ambitious growth strategies and key upcoming milestones, including expansion into new…

Continue Reading

FridayDec 10, 2021 11:11 am

ChineseNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Announces Publication of Technical Paper on Biophysics-Based CDA Cancer Detection Technology

AnPac Bio (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, today announced that its joint technical paper on novel Cancer Differentiation Analysis (“CDA”) Technology for multi-cancer screening with multiple leading medical institutions was accepted and published online. The piece was published on Nov. 30 by the Expert Review of Molecular Diagnostics, a peer-reviewed international medical journal that has an impact factor of 5.2. “We are very pleased with the publication of our technical paper on CDA cancer detection technology by a peer-reviewed international journal in the field of medicine,” said Dr. Chris Yu, AnPac Bio’s…

Continue Reading

Contact us: (310) 299-1717